Isodine

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Isodine

Quick Facts

Property Description
Active ingredient Povidone-Iodine
Pharmacological class Antiseptic and Disinfectant (Microbicide)
Origin/Type Synthetic Iodophor Complex
Common forms Solution, Ointment, Spray
Route of use Topical Application

What Type of Medicine is Isodine? (Identity, Class, and Purpose)

Isodine is a recognized trade name for a medicine containing the active ingredient Povidone-Iodine, which is globally classified as an antiseptic and disinfectant. The product belongs to the pharmacological class of microbicides, meaning its fundamental purpose is the broad elimination or inhibition of harmful microorganisms. It is intended for topical application to reduce the presence of pathogens on the skin and mucous membranes, a capability that is clinically recognized for its role in minor wound care and preparatory skin cleansing. The World Health Organization includes this essential substance in its Model List of Essential Medicines.

Composition and Physical Forms (Origin, Ingredient, and Variation)

The core substance is Povidone-Iodine, a synthetic iodophor characterized by the polymer carrier Povidone stabilizing the potent germ-killing element, Molecular Iodine. This unique complexation chemistry is a distinctive feature of the formulation, as it ensures the active element is released gradually upon contact, offering prolonged activity compared to simpler iodine tinctures. The medication is commonly supplied in several pharmaceutical preparations suitable for various needs, including an aqueous solution, an ointment, and a spray, all designed for topical application.

How Does Povidone-Iodine Function as a Microbicide? (High-Level Mechanism)

Povidone-Iodine functions as a non-specific germicide by releasing molecular iodine, which rapidly oxidizes key structural components of microbial cells. This direct chemical action is fundamental to its role as a potent microbicide. The resulting action is effective against a vast range of pathogens, being bactericidal, virucidal, and fungicidal, confirming its status as a robust broad-spectrum antimicrobial agent used in contexts requiring effective microbial elimination.

Regulatory References

  1. WHO Essential Medicines List

What side effects are possible with Isodine?

Possible Side Effects and Safety Information

The safety profile of Isodine (Povidone-Iodine) is officially documented by regulatory authorities, with adverse reactions generally classified by frequency and affected organ system. The most commonly documented reactions involve the Skin and Subcutaneous Tissue Disorders.

Adverse Reaction Classifications

Reactions involving local application are officially listed, including contact dermatitis, skin irritation, erythema (redness), and blisters. While these local effects are frequently observed, many severe or systemic reactions are classified as Rare or Frequency Not Known (meaning the frequency cannot be reliably estimated from available data).

Serious, low-frequency reactions are documented under Immune System Disorders, such as anaphylactic reactions (including shock), and Endocrine Disorders, which involve abnormal thyroid function (hypothyroidism or hyperthyroidism) and goitre.

Safety Considerations for Duration and Populations

Risk is officially linked to exposure, as prolonged or extensive application over large areas of the body or broken skin increases the potential for systemic iodine absorption. This absorption is associated with serious outcomes like metabolic acidosis and acute renal failure.

Specific population-specific safety constraints are stated in regulatory labels. Neonates and pre-term infants are at a higher documented risk of developing abnormal thyroid function. Similarly, individuals with pre-existing thyroid disorders, as well as pregnant and breastfeeding women, are cautioned against regular or prolonged use due to the potential for iodine toxicity and systemic effects, as established in official regulatory documents.

Overdose and Emergency Response

Overdose and When to Seek Help

The official regulatory profile for Povidone-Iodine overdose is defined by the consequences of acute ingestion or extensive topical application leading to systemic absorption.

Documented Overdose Presentations and Severe Outcomes

Classification Manifestations and Outcomes
Gastrointestinal Corrosive gastroenteritis, severe abdominal pain, vomiting, and bloody diarrhea.
Systemic/Metabolic Metabolic acidosis, hypernatremia, electrolyte imbalance, and abnormal blood osmolarity.
Severe Outcomes Acute renal failure, circulatory collapse (shock), pulmonary edema, and laryngeal edema.

Emergency Actions and Required Monitoring

Regulatory documentation emphasizes that if Povidone-Iodine is swallowed, individuals must seek immediate medical attention or contact a Poison Control Center right away. There is no specific antidote known; therefore, treatment is officially described as symptomatic and supportive. Management procedures documented in regulatory sources include monitoring of renal, thyroid, and liver function due to the risk of severe iodine-induced toxicity. Haemodialysis may be required in cases progressing to acute renal failure.

Population-Specific Considerations

Special risk groups identified in official labeling include neonates and small infants who are susceptible to hypothyroidism, and patients with pre-existing renal impairment or thyroid disease who face heightened risks of toxicity.

Therapeutic Uses of Isodine

The utility of Isodine (Povidone-Iodine) centers on providing infection prevention against various common pathogens across several key settings. The product is relevant for easing symptoms that are linked to localized microbial presence.

Isodine is generally used for managing symptoms associated with minor skin injuries, is applied in addressing the microbial risks associated with procedures in clinical settings, may assist with oropharyngeal irritation, and is relevant for easing symptoms in chronic ulcers. This medication helps address symptom clusters that may appear suddenly, such as redness and soreness in minor cuts, scrapes, and abrasions, and irritation of the throat. This application provides supportive relief when symptoms interfere with routine activities. For many, its use is relevant in home first aid, applied in situations requiring short-term symptomatic support for infection prevention. Its use contributes to easing the overall symptom load during episodes of heightened discomfort.


Quick Fact: Support for Localized Discomfort Use Category Condition Categories
First Aid Minor cuts, scrapes, and abrasions
Antisepsis Pre-operative preparation, injections
Symptomatic Sore throat, mucosal irritation

Regulatory References

  1. NIH DailyMed overview on Povidone-Iodine

Eligibility and Restrictions for Use

Who can and cannot use Isodine?

Regulatory documents define specific population eligibility rules for using Povidone-Iodine, primarily based on patient sensitivity and thyroid status.

Population/Condition
Populations Contraindicated (Must Not Use)
Individuals with known hypersensitivity to iodine or povidone [HPRA SmPC].
Patients with manifest thyroid diseases such as hyperthyroidism [HPRA SmPC].
Patients who are before or after radioactive iodine therapy [HPRA SmPC].
Populations Requiring Restricted Use
Newborns and small infants (use must be kept to the absolute minimum due to the risk of hypothyroidism) [NAFDAC].
Pregnant and breastfeeding women (use is restricted to the absolute minimum and only if strictly indicated) [HPRA SmPC].
Patients with goitre, thyroid nodules, or impaired renal function (use should be limited and may require caution) [HPRA SmPC].
Established Use
Adults and the general population are eligible for standard topical use on minor cuts, scrapes, and burns [NIH DailyMed].

What should I know about interactions with other medicines?

Interactions with other medicines and products

Official regulatory documents define the interaction profile of Povidone-Iodine based on its chemical properties and the potential for systemic iodine absorption.

Documented Pharmacodynamic Interactions

Topical co-administration with several substances may result in a formal weakening of the effects of both preparations. This category includes enzymatic wound treatment preparations (such as Collagenase), Hydrogen Peroxide, and Taurolidine. Concomitant use with disinfectants containing silver or mercury should be avoided due to chemical reaction, potentially leading to inactivation or caustic complexes.

Contraindicated and Restricted Combinations

Use is prohibited immediately before and after diagnostic or therapeutic procedures involving radioactive iodine (e.g., scintigraphy or therapy) as it can interfere with iodine uptake. Regulatory labeling restricts the regular or prolonged application of Povidone-Iodine in patients receiving systemic Lithium therapy, due to the formally stated additive risk of inducing hypothyroidism.

Timing and Population Notes

The label specifies that Povidone-Iodine must not be used concomitantly or immediately after Octenidine-based antiseptics on the same site to prevent transient dark discoloration. The risk of clinically significant interactions is elevated in patients with thyroid disorders and neonates, and is formally tied to conditions that increase systemic iodine exposure, such as application over large skin areas or for prolonged durations. The product can also interfere with certain diagnostic tests for blood and glucose in the urine or stool.

Mechanism of Action

Core Mechanism: Non-Selective Oxidation and Denaturation

This mechanism begins with the release of free iodine, which acts as a highly reactive, non-selective oxidizing agent. The iodine rapidly attacks and interacts with essential microbial macromolecules, including proteins, enzymes, and nucleic acids. This immediate chemical interaction leads to molecular denaturation and the irreversible destruction of the pathogen's machinery and structure, subsequently rendering the pathogen non-viable.


Broad-Spectrum Structural Disruption

This domain describes the widespread action of the drug against various microbial types, including bacteria, viruses, fungi, and spores. The oxidation mechanism rapidly degrades the structural components of these organisms, notably the cell walls and cell membranes. This physical disruption prevents the microorganism from maintaining its structural integrity or reproductive capacity, resulting in a significant and non-specific reduction in microbial load at the site of application.

Dosage and Administration Information

Instruction Map: How to use Isodine — Administration Guidelines

The administration of Isodine (Povidone-Iodine) is strictly limited to external routes, with precise instructions for application, frequency, and duration.

Category Instructions
Route of administration Restricted to Topical application (skin, wounds), Oromucosal (gargle/rinse), and Ophthalmic (eye drops) routes.
Dosing schedule Topical antiseptic: Apply a small amount to cover the area. Oromucosal: Gargle 10 mL of the solution. Ophthalmic: Instill 2 to 3 drops for pre-procedural antisepsis.
Frequency and duration First aid application is typically 1 to 3 times daily. Oromucosal solutions may be used up to 4 times daily. Topical self-medication should not exceed one week without consulting a healthcare provider.
Preparation requirements Oromucosal forms, once used for gargling, must be spit out and must not be swallowed. Ophthalmic preparations require thorough rinsing with sterile saline following the specified contact time.
Age-group rules The gargle solution is generally contraindicated in children under 6 years of age. Specific topical products may be contraindicated in infants under one year.

Resulting procedural structure Application guidelines emphasize:

  • The selected form must correspond to the approved route (e.g., solution for skin, gargle for mouth).
  • Dilution may be necessary for concentrates, and the product must be applied to a clean area.
  • A required contact time (e.g., 30 seconds to 2 minutes) must be observed, followed by mandatory rinsing or expectoration.

Connection to the overall use protocol These instructions standardize the proper administration of the microbicide, defining how much product to use and how often it should be applied to the affected site. These parameters govern the appropriate duration of use and specify necessary preparation steps, ensuring the product is administered only through its intended external routes.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Isodine (Povidone-Iodine)

This document provides an overview of the research structure and the types of studies that have examined the properties of Isodine (Povidone-Iodine). This information focuses strictly on the evidence landscape and does not offer any clinical advice or interpretation regarding safety or use.


Evidence for Use in Surgical Site Infection Prevention

The most extensive research on Povidone-Iodine relates to its application in clinical settings, where studies explore infection dynamics. This evidence base primarily includes high-level research such as systematic reviews and Randomized Controlled Trials (RCTs). Researchers monitored the evolution of infection rates and assessed measurements of microbial load on the skin during surgical preparation. What studies reported were measurements of SSI rates in different patient groups. However, the application method (concentration and contact time) was not consistent across all trials; this heterogeneity was associated with varying reported measurements.


Evidence for Use in Minor Wound Care and First Aid

Research exploring use for simple first-aid applications like minor cuts and scrapes includes observational and comparative effectiveness studies. The evidence for this application is often viewed alongside the data available from surgical trials. Researchers monitored infection rates in minor wounds and evaluated metrics related to wound closure. For specific clinical situations, Povidone-Iodine was evaluated in studies focused on the decolonization of certain bacteria. For minor first-aid injuries, however, the sample sizes were modest in some focused trials, and the follow-up durations were limited.


What is Still Uncertain About the Research Evidence

Data for certain groups remain insufficient or are often based on smaller, specialized studies, including long-term outcomes for children, pregnant populations, and individuals with specific comorbidities. The long-term effects are not fully established, meaning studies do not provide comprehensive insight into patterns that may be associated with prolonged or repeated use over many years. Furthermore, observed measurements were inconsistent in some comparative analyses due to a lack of standardization in how Povidone-Iodine was applied.

Key Studies & References

  1. Chlorhexidine versus povidone-iodine for surgical site infection prevention: an updated meta-analysis and trial sequential analysis of randomized controlled trials
  2. Povidone iodine - WHO Model Lists of Essential Medicines (eEML)
  3. Povidone Iodine Topical Solution USP - FDA DailyMed Label

Frequently Asked Questions (FAQ)

Common questions about Isodine (FAQ)

Q: Is Isodine the same type of product as Betadine?

A: Isodine and Betadine are different brand names that are used to market products containing the same active pharmaceutical ingredient, Povidone-Iodine (PVP-I). From a regulatory perspective, they are the same type of medication with the same fundamental purpose.

Q: Is Isodine generally safe for repeated use?

A: Regulatory documents advise caution against repeated or prolonged use. This warning is emphasized when applying the product over large areas or in populations known to be at higher risk of increased iodine absorption, such as infants and pregnant women.

Q: How quickly is Isodine described as working in official documentation?

A: Official product information indicates that the antiseptic effect of Povidone-Iodine begins rapidly, often within about 30 seconds of contact. Regulatory guidelines often specify that to achieve the intended effect, contact times of one minute or more may be utilized or recommended by the product label.

Q: Is Isodine considered a prescription medicine or over-the-counter?

A: In most regions, the standard topical solutions and forms of Povidone-Iodine, such as Isodine, are classified as Over-the-Counter (OTC) medicines. This means they are generally available for purchase without a medical prescription for first aid purposes.

Q: Can Isodine lose its effectiveness over time if stored incorrectly?

A: Regulatory documents specify strict storage conditions for Povidone-Iodine, including keeping it at controlled room temperature and protected from light. If the product is stored incorrectly, such as by exposing it to excessive heat or light, this may lead to a reduction of available iodine and a loss of the intended antimicrobial efficacy.

Q: Are there any reported cases of Isodine causing skin sensitivity over time?

A: Adverse event reports, noted in official safety information, indicate that Povidone-Iodine can, in rare instances, be associated with severe irritant reactions or allergic contact dermatitis (a type of delayed skin sensitivity).

Q: Can the color of Isodine vary, and does it affect its purpose?

A: The dark brown color of the Povidone-Iodine solution is an essential characteristic that signals the presence of active iodine. According to product guidelines, the product’s intended antimicrobial activity is maintained only while this color remains visible on the application site.

Q: What are the basic ingredients other than Povidone-iodine in Isodine?

A: Regulatory documents list other basic ingredients, known as excipients, that help stabilize the solution. These non-active substances commonly found in Povidone-Iodine products include purified water, glycerin, sodium hydroxide, and citric acid.

Q: Do regulatory warnings specify using Isodine with certain medical devices?

A: Regulatory warnings indicate that Povidone-Iodine can be chemically incompatible with certain substances. These include preparations containing mercury, silver, and hydrogen peroxide, as concomitant use may weaken the effects or create caustic complexes.

Q: What happens if someone accidentally swallows a small amount of Isodine?

A: Regulatory safety information warns that in the event Povidone-Iodine is accidentally swallowed, inducing vomiting is not recommended unless specifically advised by a healthcare professional. The required action is to immediately seek medical attention or contact a poison control center.

Q: Is Isodine described as irritating to broken skin?

A: While Povidone-Iodine is intended for use on minor cuts and scrapes, official warnings indicate that application can cause localized effects such as mild skin irritation, redness, or dryness. The product label states that if irritation, sensitization, or burning occurs, use should be discontinued.

Q: What is the difference between an antiseptic and a disinfectant, in the context of Isodine?

A: Regulatory classification defines Povidone-Iodine as an antiseptic, which is a type of chemical agent used to reduce the presence of microorganisms. Antiseptics are specifically approved for application on living tissues, such as the skin and mucous membranes.

Q: Is there guidance on using Isodine near the eyes or mucus membranes?

A: General topical solutions often carry warnings against contact with the eye, but a specialized ophthalmic formulation is approved for pre-surgical preparation of the eye surface (conjunctiva). The instructions for administration of this specialized product specify thorough rinsing with sterile saline following the procedure.

Q: Isodine described as having a temporary or lasting effect on microorganisms?

A: The formulation uses a complex to facilitate the slow and sustained release of active iodine, which is its microbicidal component. Pharmacological documents describe this mechanism as providing an effect that is longer lasting compared to simpler iodine solutions.

Q: What is the general distinction between Isodine and pure iodine?

A: Isodine contains Povidone-Iodine, which is a complex where the active iodine is bound to a polymer carrier. This chemical structure allows the iodine to be released gradually, which is associated with a lower potential for skin irritation and a longer duration of action compared to traditional pure iodine tinctures.

How should Isodine be stored and disposed of?

How to Store and Dispose of Povidone-Iodine (Isodine)

Povidone-Iodine must be stored according to official regulatory labeling to maintain stability.

Storage Requirements

Storage Factor Required Condition
Temperature Store at controlled room temperature (15 C to 30 C).
Protection Protect from light; keep from freezing or excessive heat.
Container Keep the container tightly closed when not in use.
Safety Keep out of reach of children.

Disposal Instructions

Disposal must follow pharmaceutical guidelines. The preferred method for unused or expired product is a drug take-back program. If a take-back program is unavailable, the medicine should be mixed with an unappealing substance, sealed in a bag, and discarded in the household trash. Single-use applicators must be discarded after single use.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Isodine found in:

A-Z Index: